Clinical Trial Update: Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluated pyrazoloacridine administered before radiation therapy in adults with newly diagnosed supratentorial glioblastoma multifor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pyrazoloacridine (pyrazoloacridine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED